152 related articles for article (PubMed ID: 38213166)
1. Radiopharmaceuticals: A New Vista for Diagnosis and Treatment of Thyroid Cancer.
Vernekar S; Budha RR; Alavala RR
Curr Radiopharm; 2024 Jan; ():. PubMed ID: 38213166
[TBL] [Abstract][Full Text] [Related]
2. Differentiated thyroid cancer theranostics: radioiodine and beyond.
Choudhury PS; Gupta M
Br J Radiol; 2018 Nov; 91(1091):20180136. PubMed ID: 30260232
[TBL] [Abstract][Full Text] [Related]
3. RADIOISOTOPE DIAGNOSTIC ALGORITHM FOR THE RELAPSE AND METASTASES DETECTION IN THE IODINE-NEGATIVE DIFFERENTIATED THYROID CANCER.
Solodyannikova OI; Kmetyuk YV; Danilenko VV; Sukach GG
Probl Radiac Med Radiobiol; 2020 Dec; 25():579-591. PubMed ID: 33361863
[TBL] [Abstract][Full Text] [Related]
4. The Role of Radiopharmaceuticals in Amiodarone-Induced Thyroid Pathology.
Irimie A; Piciu D
Curr Radiopharm; 2017 Nov; 10(3):146-154. PubMed ID: 28814251
[TBL] [Abstract][Full Text] [Related]
5. A Review of the History of Radioactive Iodine Theranostics: The Origin of Nuclear Ontology.
Ehrhardt JD; Güleç S
Mol Imaging Radionucl Ther; 2020 Oct; 29(3):88-97. PubMed ID: 33094571
[TBL] [Abstract][Full Text] [Related]
6. Radioiodine scintigraphy with SPECT/CT: an important diagnostic tool for thyroid cancer staging and risk stratification.
Avram AM
J Nucl Med Technol; 2014 Sep; 42(3):170-80. PubMed ID: 25190758
[TBL] [Abstract][Full Text] [Related]
7. Updated Review of Nuclear Molecular Imaging of Thyroid Cancers.
Fu H; Sa R; Cheng L; Jin Y; Qiu X; Liu M; Chen L
Endocr Pract; 2021 May; 27(5):494-502. PubMed ID: 33934754
[TBL] [Abstract][Full Text] [Related]
8. The Use of 123I in Diagnostic Radioactive Iodine Scans in Children with Differentiated Thyroid Carcinoma.
Schoelwer MJ; Zimmerman D; Shore RM; Josefson JL
Thyroid; 2015 Aug; 25(8):935-41. PubMed ID: 25978106
[TBL] [Abstract][Full Text] [Related]
9. Controversies, Consensus, and Collaboration in the Use of
Tuttle RM; Ahuja S; Avram AM; Bernet VJ; Bourguet P; Daniels GH; Dillehay G; Draganescu C; Flux G; Führer D; Giovanella L; Greenspan B; Luster M; Muylle K; Smit JWA; Van Nostrand D; Verburg FA; Hegedüs L
Thyroid; 2019 Apr; 29(4):461-470. PubMed ID: 30900516
[TBL] [Abstract][Full Text] [Related]
10. Incremental diagnostic value of SPECT/CT with 131I scintigraphy after radioiodine therapy in patients with well-differentiated thyroid carcinoma.
Maruoka Y; Abe K; Baba S; Isoda T; Sawamoto H; Tanabe Y; Sasaki M; Honda H
Radiology; 2012 Dec; 265(3):902-9. PubMed ID: 23012466
[TBL] [Abstract][Full Text] [Related]
11. Advances in Functional Imaging of Differentiated Thyroid Cancer.
Klain M; Zampella E; Nappi C; Nicolai E; Ambrosio R; Califaretti E; Lamartina L; Schlumberger M; Deandreis D; Salvatore D; Cuocolo A
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638232
[TBL] [Abstract][Full Text] [Related]
12. Low-iodine diet revisited: importance in nuclear medicine imaging and management.
Hinds SR; Stack AL; Stocker DJ
Clin Nucl Med; 2008 Apr; 33(4):247-50. PubMed ID: 18356660
[TBL] [Abstract][Full Text] [Related]
13. [SPECT/CT for staging and treatment monitoring in oncology. Applications in differentiated thyroid cancer and liver tumors].
Weber K; Berger F; Mustafa M; Reiser MF; Bartenstein P; Haug A
Radiologe; 2012 Jul; 52(7):646-52. PubMed ID: 22710988
[TBL] [Abstract][Full Text] [Related]
14. Assessment of lesion response in the initial radioiodine treatment of differentiated thyroid cancer using 124I PET imaging.
Jentzen W; Hoppenbrouwers J; van Leeuwen P; van der Velden D; van de Kolk R; Poeppel TD; Nagarajah J; Brandau W; Bockisch A; Rosenbaum-Krumme S
J Nucl Med; 2014 Nov; 55(11):1759-65. PubMed ID: 25332440
[TBL] [Abstract][Full Text] [Related]
15. Use of imaging tests after primary treatment of thyroid cancer in the United States: population based retrospective cohort study evaluating death and recurrence.
Banerjee M; Wiebel JL; Guo C; Gay B; Haymart MR
BMJ; 2016 Jul; 354():i3839. PubMed ID: 27443325
[TBL] [Abstract][Full Text] [Related]
16. Molecular imaging in the management of thyroid cancer.
Wong KK; Dvorak RA; Marzola MC; Grassetto G; Gross MD; Rubello D
Q J Nucl Med Mol Imaging; 2011 Oct; 55(5):541-59. PubMed ID: 22019711
[TBL] [Abstract][Full Text] [Related]
17. Conventional Radioiodine Therapy for Differentiated Thyroid Cancer.
Ylli D; Van Nostrand D; Wartofsky L
Endocrinol Metab Clin North Am; 2019 Mar; 48(1):181-197. PubMed ID: 30717901
[TBL] [Abstract][Full Text] [Related]
18. Functional and molecular thyroid imaging.
Giovanella L; Petranović Ovčariček P
Q J Nucl Med Mol Imaging; 2022 Jun; 66(2):86-92. PubMed ID: 35166094
[TBL] [Abstract][Full Text] [Related]
19. [Radioactive iodine in the treatment of Graves' disease: history and modern concept of radionuclide therapy].
Sheremeta MS; Korchagina MO; Pesheva ED; Fadeev VV
Ter Arkh; 2022 Nov; 94(10):1211-1215. PubMed ID: 36468997
[TBL] [Abstract][Full Text] [Related]
20. Outcome of patients with differentiated thyroid cancer treated with empirical radioiodine therapy on the basis of Thyroglobulin Elevation Negative Iodine Scintigraphy (TENIS) syndrome without structural disease: a retrospective cohort study.
Yuan L; Wang J; Pan L; Feng H; Chen P; Luo J; Xie J; Xiong X; Wu J; Ouyang W
Ann Nucl Med; 2023 Jan; 37(1):18-25. PubMed ID: 36318362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]